2. Methods
CHRONIC GASTRITIS, MAY
This phase 3 study was a multicenter, randomized, double-blind, parallel-group, phase III clinical trial to evaluate the efficacy and safety of CKD-495 in patients with acute or chronic gastritis. The study was conducted at 17 Korean hospitals from January 2020 to May 2021. The study protocol was reviewed and approved by the institutional review board of each hospital according to the ethical principles of the Declaration of Helsinki and Good.Clinical Practice (Supplementary Data, Table S1, 